Get addiction help now: (831) 315-4540

get help now

Get addiction help now: (831) 315-4540

get help now

Statement About MMT from NIDDK

Time to read: 2 min

From NIDDK Fact Sheet

Chronic Hepatitis C: Current Disease Management

“Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol or substance abuse. Typically a 6-month abstinence is recommended before starting therapy, but this should be applied only to patients with a history of alcohol abuse, not to social drinkers. Patients with continuing alcohol or substance abuse problems should only be treated in collaboration with alcohol or substance abuse specialists or counselors. Patients can be successfully treated while on methadone or in an active substance abuse program. Indeed, the rigor and regular monitoring that accompany methadone treatment provide a structured format for combination therapy. The dose of methadone may need to be modified during interferon-based therapy for hepatitis.”

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health under the U.S. Department of Health and Human Services.

From: NIH Publication No. 03-4230 February 2003

Similar Posts

  • Make a Donation

    ByAdmin
    Admin 11/13/2022

    NAMA receives no funding for our advocacy work or to maintain our websites. Won’t you please consider making a donation? Making a Donation by Personal Check Checks or Money Orders should be made out to the: National Alliance of Methadone Advocates Mail it to: National Alliance of Methadone Advocates 435 Second Avenue New York, NY…

  • Click Page!

    ByAdmin
    Admin 04/11/2023

    How to use the Click Page The Click Page helps NAMA earn money. Clicking on a banner can earn from $.05 to $1 or more. All you have to do is go down the page and click on each banner. A window will open, wait a few seconds and then close it. You will find…

  • Grievance Report

    ByAdmin
    Admin 04/02/2022

    Is Your Program Punitive? Fill Out a Grievance Report — It’s Time To Educate Them! Does Your Program Treat Patients With Dignity? Fill Out a Compliment Report — Let Them Know They are Appreciated! The Grievance Report Project is an ongoing project used to educate the Medication Assisted Treatment (MAT) community about quality treatment. Programs…

  • Publication Index

    ByAdmin
    Admin 03/18/2022

    FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…

  • Reception

    ByAdmin
    Admin 08/15/2021

    Welcome to The President’s Office and to the National Alliance for Medication Assisted Recovery or NAMA Recovery. NAMA Recovery has gone through some significant changes in the past few years. We are proud of the MARS Project the first project of its kind that provides recovery services to patients receiving Medication Assisted Treatment (MAT). As…